(Q56864380)

12 December 2020

Overview of comorbid associations of allergic rhinitis

1 reference

12 December 2020

Efficacy and tolerability of levocabastine and azelastine nasal sprays for the treatment of allergic rhinitis

1 reference

12 December 2020

Inhibitory effects of azelastine on superoxide anion generation from activated inflammatory cells measured by a simple chemiluminescence method.

1 reference

12 December 2020

Interference of anti-inflammatory and anti-asthmatic drugs with neutrophil-mediated platelet activation: singularity of azelastine

1 reference

12 December 2020

Topical therapy of allergic rhinitis in childhood: Allergodil nasal spray--non-sedating in children

1 reference

12 December 2020

Levocabastine. An update of its pharmacology, clinical efficacy and tolerability in the topical treatment of allergic rhinitis and conjunctivitis

1 reference

12 December 2020

Study protocol on azelastine

1 reference

12 December 2020

A multicenter clinical study of the efficacy and tolerability of azelastine nasal spray in the treatment of seasonal allergic rhinitis: a comparison with oral cetirizine

1 reference

12 December 2020

A double-blind, controlled trial to assess the safety and efficacy of azelastine nasal spray in seasonal allergic rhinitis

1 reference

12 December 2020

A randomized double-blind placebo controlled study of azelastine nasal spray in children with perennial rhinitis

1 reference

12 December 2020

A comparison of azelastine nasal spray and cetirizine tablets in the treatment of allergic rhinitis

1 reference

12 December 2020

Efficacy and tolerability of azelastine nasal spray in the treatment of allergic rhinitis: large scale experience in community practice

1 reference

12 December 2020

Efficacy and tolerability of azelastine nasal spray in patients with allergic rhinitis compared to placebo and budesonide.

1 reference

12 December 2020

A dose-ranging study of the efficacy and safety of azelastine nasal spray in the treatment of seasonal allergic rhinitis with an acute model

1 reference

12 December 2020

Azelastine nasal spray as adjunctive therapy to azelastine tablets in the management of seasonal allergic rhinitis

1 reference

12 December 2020

Suppression of TNF-alpha secretion by azelastine in a rat mast (RBL-2H3) cell line: evidence for differential regulation of TNF-alpha release, transcription, and degranulation

1 reference

12 December 2020

Azelastine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential

1 reference

12 December 2020

Topical azelastine has a 12-hour duration of action as assessed by histamine challenge-induced exudation of alpha 2-macroglobulin into human nasal airways

1 reference

12 December 2020

Topical azelastine reduces eosinophil activation and intercellular adhesion molecule-1 expression on nasal epithelial cells: an antiallergic activity

1 reference

12 December 2020

The effect of intranasal azelastine, Rhinolast, on nasal airways obstruction and sneezing following provocation testing with histamine and allergen

1 reference

12 December 2020

Calcium as intracellular messenger: sensitivity modulation, C-kinase pathway, and sustained cellular response

1 reference

12 December 2020

Inhibitory effects of azelastine on protein kinase C and diphosphoinositide kinase in rat mast cells

1 reference

12 December 2020

Effects of anti-allergic drugs on human neutrophil superoxide-generating NADPH oxidase

1 reference

12 December 2020

Effects of azelastine hydrochloride, a novel anti-allergic drug, on the central nervous system

1 reference

12 December 2020

Sedation in allergic rhinitis is caused by the condition and not by antihistamine treatment

1 reference

12 December 2020

Activation of human neutrophil nicotinamide adenine dinucleotide phosphate, reduced (triphosphopyridine nucleotide, reduced) oxidase by arachidonic acid in a cell-free system

1 reference

12 December 2020

Ebastine. a review of its pharmacological properties and clinical efficacy in the treatment of allergic disorders

1 reference

12 December 2020

Tolerability and pharmacokinetics of single and multiple doses of azelastine hydrochloride in elderly volunteers.

1 reference

12 December 2020

Leukotriene B4 is a potent and stereospecific stimulator of neutrophil chemotaxis and adherence

1 reference

12 December 2020

The effect of azelastine on neutrophil and eosinophil generation of superoxide

1 reference

12 December 2020

Psychometric aspects of antihistamines

1 reference

12 December 2020

Azelastine nasal spray in the management of seasonal allergic rhinitis

1 reference

12 December 2020

Levocabastine. A review of its pharmacological properties and therapeutic potential as a topical antihistamine in allergic rhinitis and conjunctivitis

1 reference

12 December 2020

Leukotriene B, a potent chemokinetic and aggregating substance released from polymorphonuclear leukocytes

1 reference

12 December 2020

Investigation of long-term efficacy and tolerability of azelastine nasal spray in the treatment of perennial allergic rhinitis

1 reference

12 December 2020

Azelastine and allergen transduction signal in MC9 mast cells

1 reference

12 December 2020

Allergic rhinitis: clinical practice guideline. Committee on Practice Standards, American Academy of Otolaryngic Allergy

1 reference

12 December 2020

Effects of anti-allergy drugs on fMet-Leu-Phe-stimulated superoxide generation in human neutrophils

1 reference

12 December 2020

Inhibitory effects of azelastine hydrochloride on Ca2+ influx, actin polymerization and release of eosinophil cationic protein of an eosinophilic leukaemia cell line EoL-1.

1 reference

12 December 2020

Effect of intranasal azelastine and beclomethasone dipropionate on nasal symptoms, nasal cytology, and bronchial responsiveness to methacholine in allergic rhinitis in response to grass pollens

1 reference

12 December 2020

Comparative efficacy of azelastine nasal spray and terfenadine in seasonal and perennial rhinitis

1 reference

12 December 2020

The activity of recent anti-allergic drugs in the treatment of seasonal allergic rhinitis.

1 reference

12 December 2020

Intranasal treatment of perennial allergic rhinitis. Comparison of azelastine nasal spray and budesonide nasal aerosol

1 reference

12 December 2020

Tolerability, pharmacokinetics and dose linearity of azelastine hydrochloride in healthy subjects

1 reference

12 December 2020

The pharmacology and mechanisms of action of histamine H1-antagonists

1 reference

12 December 2020

Safety and efficacy of azelastine nasal spray (Astelin NS) for seasonal allergic rhinitis: a 4-week comparative multicenter trial

1 reference

12 December 2020

Comparison of azelastine nasal spray and oral ebastine in treating seasonal allergic rhinitis

1 reference

12 December 2020

A placebo controlled study comparing the efficacy of intranasal azelastine and beclomethasone in the treatment of seasonal allergic rhinitis

1 reference

12 December 2020

Activation of the respiratory burst enzyme from human neutrophils in a cell-free system. Evidence for a soluble cofactor

1 reference

12 December 2020

Effects of azelastine on neutrophil chemotaxis, phagocytosis and oxygen radical generation

1 reference

12 December 2020

Participation of histamine in the step-through active avoidance response and its inhibition by H1-blockers

1 reference

12 December 2020

Effectiveness of azelastine nasal solution in seasonal allergic rhinitis

1 reference

12 December 2020

Seasonal rhinitis and azelastine: long- or short-term treatment?

1 reference

12 December 2020

The role of leukotrienes in asthma and allergic rhinitis

1 reference

12 December 2020

Second-generation H1-receptor antagonists.

1 reference

12 December 2020

Azelastine reduces histamine-induced swelling of nasal mucosa

1 reference

12 December 2020

Action sites of antiallergic drugs on human neutrophils

1 reference

12 December 2020

Seasonal allergic rhinitis

1 reference

12 December 2020

A comparison of the efficacy of azelastine nasal spray and loratidine tablets in the treatment of seasonal allergic rhinitis

1 reference

12 December 2020

The effect of intranasal azelastine and beclomethasone on the symptoms and signs of nasal allergy in patients with perennial allergic rhinitis

1 reference

12 December 2020

The pharmacological basis for the treatment of perennial allergic rhinitis and non‐allergic rhinitis with topical corticosteroids

1 reference

12 December 2020

Evaluation of the drug monitoring programme of azelastine hydrochloride nasal spray in the treatment of allergic rhinitis in children under 13 years of age

1 reference

12 December 2020